Beyond Glioma: The Utility of Radiomic Analysis for Non-Glial Intracranial Tumors

The field of radiomics is rapidly expanding and gaining a valuable role in neu-ro-oncology. The possibilities related to the use of radiomic analysis, such as distinguishing types of malignancies, predicting tumor grade, determining the presence of particular molecular mark-ers, consistency, therapy response, and prognosis, can considerably influence decision-making in medicine in the near future. Even though the main focus of radiomic analyses has been on glial CNS tumors, studies on other intracranial tumors have shown encouraging results. Therefore, as the main focus of this review, we performed an analysis of publications on PubMed and Web of Science databases, focusing on radiomics in CNS metastases, lymphoma, meningioma, medullo-blastoma, and pituitary tumors.